Read review Dihexa for Autism Spectrum Disorder (ASD) The Campbell rs1858830 MET promoter C-allele autism finding (the strongest mechanistic anchor to Dihexa pharmacology), the January 2026 mGluR5 PET 16-23% lower availability, the December 2025 DAYBUE STIX (trofinetide) Rett approval, the March 2026 FDA leucovorin decision (CFD only, not autism), the 270,701 NHS open referrals breaching NICE NG142, and the ~700,000 UK autistic population
Initial setup costs for an IV therapy practice typically range from $10,000 to $50,000, depending on the scope of your operation
10.3390/antiox6040098 53 Colunga BiancatelliR
M., Summers, R
The peptides effects on nitric oxide systems theoretically could interact with blood pressure medications, erectile dysfunction drugs, and other compounds affecting NO pathways
doi: 10.1007/s10989-022-10365-6 170 LitvackM